Douglas S. Bireley has been appointed Executive Vice President, Marketing and Research & Development of Surgalign, effective August 17, 2020. The news was announced today.
Douglas S. Bireley joins Surgalign with over 20 years of Spine experience in marketing and product development with a strong record of accomplishment in brand strategy, technology innovation, and business development. He has led marketing and R&D teams for a major Fortune 50 company and holds a Bachelor of Science degree in business administration from Bucknell University. Bireley will report directly to Terry Rich, President and Chief Executive Officer of Surgalign and will be based in San Diego, California.
“We are excited to welcome Doug as the final member of our best-in-class executive leadership team at Surgalign. I’m confident that his in-depth industry experience will further enhance our spine expertise, accelerate our efforts to build a leading marketing and R&D competency, and enhance our pace of innovation to advance care and improve patient outcomes,” said Rich.
Prior to joining Surgalign, Bireley was senior director of Global Strategic Marketing for Robotics & Digital Surgery at Johnson & Johnson. Bireley spent more than 20 years at Johnson & Johnson in various marketing and R&D roles of increasing responsibility, including leading the commercial integration of DePuy Spine and Synthes Spine. He also has significant international experience including time spent living overseas.